Please login to the form below

Interpharm Consultancy

30 years’ experience of the European pharmaceutical industry in general and 20 years in generics in particular gives Interpharm the background to help you with whatever issues you may be facing. Whether you are thinking about: Business development, Introducing your generic products into Europe, Market intelligence and pricing, Assistance with product licensing (in or out), How to devise an effective defence strategy to protect your brands against generic competition or Bioequivalence studies for your generic developments, please contact us. We can also help with in-house training that is tailored to your company’s individual needs on topics such as understanding the generic market and the legal and IP issues that affect it.

This is a FREE listing




Below are full profiles from other companies in this area

Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance improvement and sustainable growth by working with their leaders and teams to develop excellent strategies, capabilities, and partnerships across commercial, corporate an

View profile

Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient programmes, to designing, developing and testing new materials, we apply the wealth of evidence on what good patient communications look like.

View profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of patients is at the heart of our programmes; Sciterion are experts at rigorous insight generation and multi-stakeholder co-creation. Through a deep understanding of health behaviour, we align key stakeholder touchpoints to deliver intelligent, highly impactful and clinically relevant programmes. Our industry- leading standards of medical and scientific excellence, coupled with robust behavioural knowledge, advances clinical practice and optimises real world patient outcomes.

View profile

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices. A vision to make a positive impact on the success of our clients, the economy and the wider society.

View profile

GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting from the inside out. With global hubs in London and New York, we are the only WPP specialty healthcare communications agency – offering the agility, passion and entrepreneurial spirit of a specialist agency whilst benefiting from access to the connections and expertise of a genuine global network.

View profile

Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we provide custom solutions and strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.

View profile

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals, based in NZ, China, Singapore, UAE, Switzerland, UK and USA.

View profile

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team to help clients develop the expert partnerships they need at all points in the product launch cycle. We believe that KOL relationship-building can transform market performance. We invest all our energies in helping our clients to do it well. Kendle Healthcare is dedicated to the two key phases of KOL development: finding the right people, and working with them in the right way. Kendle’s research division conducts identification projects which deliver powerful insights into the clinician landscape in any therapy area, large or small. We take a unique and considered approach to capturing individual experts’ strengths and interests. Our findings are delivered in visually dynamic formats tailored to the working needs of medical, marketing and sales teams. Our methodology is complex, but our aim is simple: provide peace of mind by ensuring our clients identify the most influential individuals in any therapy area. Kendle’s engagement team partners with clients to design and implement a KOL programme which gets the best from those individuals. Our strategic consultancy is built on our philosophy of long-term relationship-building. Whatever the engagement activity, we never forget that we are facilitating a partnership which can and should be productive for both sides. Whatever your needs, we are the experts on experts.

View profile

OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes using high quality sales professionals, and multi-channel communication.

View profile

Market Study Report

Market Study Report is a hub for market intelligence products and services. We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

View profile

Company Details

Interpharm Consultancy

Telephone:+44 (0)20 8446 5572

Contact

Address:
55 Northiam
Woodside Park London
N12 7JH
United Kingdom

Latest content from PMHub

Oral Appliances lead Sleep Apnea Devices Market Growth, Shows Recent Analysis
Sleep apnea devices market to accrue commendable proceeds from oral appliance sales, U.S. to account for a significant share of the overall industry Market Study Report
Animal Healthcare Market is poised to cross USD 36 billion by 2024
Animal Healthcare Market is poised to cross USD 36 billion by 2024 as increasing demand for protein from animal source will be a high impact rendering factor on animal healthcare industry size. Market Study Report
Fishawack launches new website and introduces new structure for growth
The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as providing news, careers, and contact information for the expanding group, complementing Fishawack’s active presence on LinkedIn and Twitter. Fishawack Group of Companies
OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months.
OUTiCO